FDA approves Glaxo, Theravance’s Breo Ellipta asthma drug – Fox News


Fox News

FDA approves Glaxo, Theravance's Breo Ellipta asthma drug
Fox News
The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said. The FDA declined to approve Breo for younger asthma …
GlaxoSmithKline And Theravance: The Asthma Approval In FiguresSeeking Alpha
GlaxoSmithKline plc (ADR) Gets FDA Approval For Breo Ellipta To Treat Asthma Bidness ETC
FDA Okays Breo Ellipta for Asthma in AdultsMedscape
Bloomberg
all 81 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.